logo
Plus   Neg
Share
Email

FDA Approves Novartis' Ilaris To Treat Still's Disease

The U.S. Food and Drug Administration Tuesday approved Novartis AG's (NVS) Ilaris for the treatment of Active Still's disease, including Adult-Onset Still's Disease.

Ilaris was previously approved for Systemic Juvenile Idiopathic Arthritis in patients aged 2 years and older.

"Prior to today's approval, patients had no FDA-approved treatments for their disease, which can include symptoms such as painful arthritis, fevers and rash," said Nikolay Nikolov, M.D., acting director of the Division of Rheumatology and Transplant Medicine in the FDA's Center for Drug Evaluation and Research. "Today's approval provides patients with a treatment option."

Adult-Onset Still's disease is a rare and serious autoinflammatory disease that has considerable overlap with Systemic Juvenile Idiopathic Arthritis, including fever, arthritis and rash, the FDA said.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter could face a fine of up to $250 million from the U.S. Federal Trade Commission regarding its use of phone numbers and email addresses to target advertisements. Lord & Taylor joined the growing list of U.S. retailers who filed for bankruptcy amid the coronavirus pandemic. Lord & Taylor, one of the oldest department store chains in the U.S., filed for bankruptcy protection in the Eastern Court of Virginia on Sunday. The company operated 38 stores that have remained temporarily closed since March this year due to the pandemic. Thomson International Inc. is recalling Red, Yellow, White, and Sweet Yellow Onions for potential contamination with Salmonella, according to a statement by the U.S. Food and Drug Administration or FDA. The onions are in distribution since May 1, 2020. They were sold to wholesalers, restaurants, and retail stores in all 50 U.S. states, the District of Columbia and Canada.
Follow RTT